191 related articles for article (PubMed ID: 16053339)
1. Calcium dobesilate in the treatment of diabetic retinopathy.
Garay RP; Hannaert P; Chiavaroli C
Treat Endocrinol; 2005; 4(4):221-32. PubMed ID: 16053339
[TBL] [Abstract][Full Text] [Related]
2. Antioxidant properties of calcium dobesilate in ischemic/reperfused diabetic rat retina.
Szabo ME; Haines D; Garay E; Chiavaroli C; Farine JC; Hannaert P; Berta A; Garay RP
Eur J Pharmacol; 2001 Oct; 428(2):277-86. PubMed ID: 11675046
[TBL] [Abstract][Full Text] [Related]
3. Reduction of retinal albumin leakage by the antioxidant calcium dobesilate in streptozotocin-diabetic rats.
Rota R; Chiavaroli C; Garay RP; Hannaert P
Eur J Pharmacol; 2004 Jul; 495(2-3):217-24. PubMed ID: 15249173
[TBL] [Abstract][Full Text] [Related]
4. Calcium dobesilate: pharmacological profile related to its use in diabetic retinopathy.
Berthet P; Farine JC; Barras JP
Int J Clin Pract; 1999 Dec; 53(8):631-6. PubMed ID: 10692760
[TBL] [Abstract][Full Text] [Related]
5. Effect of calcium dobesilate on the blood-retinal barrier in early diabetic retinopathy.
Leite EB; Mota MC; de Abreu JR; Cunha-Vaz JG
Int Ophthalmol; 1990 Mar; 14(2):81-8. PubMed ID: 2187006
[TBL] [Abstract][Full Text] [Related]
6. Calcium dobesilate for diabetic retinopathy: a systematic review and meta-analysis.
Zhang X; Liu W; Wu S; Jin J; Li W; Wang N
Sci China Life Sci; 2015 Jan; 58(1):101-7. PubMed ID: 25528255
[TBL] [Abstract][Full Text] [Related]
7. Calcium dobesilate in diabetic retinopathy. A retrospective controlled study.
Adank C; Koerner F
Ophthalmologica; 1985; 190(2):102-11. PubMed ID: 3982791
[TBL] [Abstract][Full Text] [Related]
8. Assessment of calcium dobesilate in diabetic retinopathy. A double-blind clinical investigation.
Salama Benarroch I; Nano H; Pérez H; Elizalde F; Bisceglia H; Salama A
Ophthalmologica; 1977; 174(1):47-51. PubMed ID: 322009
[TBL] [Abstract][Full Text] [Related]
9. The effect of calcium dobesilate on nonproliferative diabetic retinopathy: a controlled study.
Stamper RL; Smith ME; Aronson SB; Cavender JC; Cleasby GW; Fung WE; Becker B
Ophthalmology; 1978 Jun; 85(6):594-606. PubMed ID: 353623
[TBL] [Abstract][Full Text] [Related]
10. Calcium Dobesilate and Micro-vascular diseases.
Liu J; Li S; Sun D
Life Sci; 2019 Mar; 221():348-353. PubMed ID: 30769115
[TBL] [Abstract][Full Text] [Related]
11. Effect of calcium dobesilate on progression of early diabetic retinopathy: a randomised double-blind study.
Ribeiro ML; Seres AI; Carneiro AM; Stur M; Zourdani A; Caillon P; Cunha-Vaz JG;
Graefes Arch Clin Exp Ophthalmol; 2006 Dec; 244(12):1591-600. PubMed ID: 16763797
[TBL] [Abstract][Full Text] [Related]
12. Calcium Dobesilate Is Protective against Inflammation and Oxidative/Nitrosative Stress in the Retina of a Type 1 Diabetic Rat Model.
Voabil P; Liberal J; Leal EC; Bauer J; Cunha-Vaz J; Santiago AR; Ambrósio AF
Ophthalmic Res; 2017; 58(3):150-161. PubMed ID: 28793297
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of streptozotocin-induced diabetic retinopathy with low molecular weight fucoidan via inhibition of vascular endothelial growth factor.
Yang W; Yu X; Zhang Q; Lu Q; Wang J; Cui W; Zheng Y; Wang X; Luo D
Exp Eye Res; 2013 Oct; 115():96-105. PubMed ID: 23810809
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of troxerutin on streptozotocin-induced rat model in the early stage of diabetic retinopathy.
Chung HK; Choi SM; Ahn BO; Kwak HH; Kim JH; Kim WB
Arzneimittelforschung; 2005; 55(10):573-80. PubMed ID: 16294503
[TBL] [Abstract][Full Text] [Related]
15. Calcium dobesilate attenuates vascular injury and the progression of diabetic retinopathy in streptozotocin-induced diabetic rats.
Padilla E; Ganado P; Sanz M; Zeini M; Ruiz E; Triviño A; Ramírez AI; Salazar JJ; Ramírez JM; Rojas B; Hoz Rd; Tejerina T
Diabetes Metab Res Rev; 2005; 21(2):132-42. PubMed ID: 15386814
[TBL] [Abstract][Full Text] [Related]
16. Safety of calcium dobesilate in chronic venous disease, diabetic retinopathy and haemorrhoids.
Allain H; Ramelet AA; Polard E; Bentué-Ferrer D
Drug Saf; 2004; 27(9):649-60. PubMed ID: 15230646
[TBL] [Abstract][Full Text] [Related]
17. Treatment of blood hyperviscosity with calcium dobesilate in patients with diabetic retinopathy.
Benarroch IS; Brodsky M; Rubinstein A; Viggiano C; Salama EA
Ophthalmic Res; 1985; 17(3):131-8. PubMed ID: 4011126
[TBL] [Abstract][Full Text] [Related]
18. The value of calcium dobesilate in the treatment of diabetic retinopathy. A controlled clinical trial.
Larsen HW; Sander E; Hoppe R
Diabetologia; 1977 Apr; 13(2):105-9. PubMed ID: 323093
[TBL] [Abstract][Full Text] [Related]
19. Effect of calcium dobesilate on occurrence of diabetic macular oedema (CALDIRET study): randomised, double-blind, placebo-controlled, multicentre trial.
Haritoglou C; Gerss J; Sauerland C; Kampik A; Ulbig MW;
Lancet; 2009 Apr; 373(9672):1364-71. PubMed ID: 19376452
[TBL] [Abstract][Full Text] [Related]
20. Calcium dobesilate prevents the oxidative stress and inflammation induced by diabetes in the retina of db/db mice.
Bogdanov P; Solà-Adell C; Hernández C; García-Ramírez M; Sampedro J; Simó-Servat O; Valeri M; Pasquali C; Simó R
J Diabetes Complications; 2017 Oct; 31(10):1481-1490. PubMed ID: 28847447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]